NYSE
According to Zyberno, CBIZ, Inc. (CBZ) is not a buy — AVERAGE BUSINESS (52/100) with a negative Margin of Safety of +4.8% and a Brina Gap of -8.5% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, CBIZ, Inc. (CBZ) trades at $54.51 against an estimated intrinsic value per share of $57.23 — a +4.8% Margin of Safety based on Owner Earnings of $175.53M TTM, projected at 9.8% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -8.5% weakens the case: based on the company's ROIC (7.8%) and reinvestment rate (-31.5%), the business can fundamentally grow at -2.5% — but the current enterprise value implies the market expects 6.1%. This places CBZ in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of 10.9% annually.
Over the trailing twelve months, CBZ generated $175.53M in Owner Earnings. Capital was deployed as follows: $16.96M invested in capital expenditures. Reinvestment rate: -31.5%. Owner Earnings have grown at 9.8% annually over the trailing five years using log-linear regression.